Bagante, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 9.274
EU - Europa 7.116
AS - Asia 5.378
SA - Sud America 861
Continente sconosciuto - Info sul continente non disponibili 232
AF - Africa 197
OC - Oceania 9
Totale 23.067
Nazione #
US - Stati Uniti d'America 8.911
RU - Federazione Russa 2.490
SG - Singapore 2.145
CN - Cina 1.503
GB - Regno Unito 1.290
IT - Italia 1.064
BR - Brasile 644
DE - Germania 478
HK - Hong Kong 457
VN - Vietnam 446
IE - Irlanda 411
FR - Francia 384
SE - Svezia 375
FI - Finlandia 203
KR - Corea 185
CA - Canada 147
UA - Ucraina 109
TR - Turchia 104
BD - Bangladesh 96
IN - India 93
AR - Argentina 79
NL - Olanda 62
NG - Nigeria 58
MX - Messico 53
IQ - Iraq 47
CR - Costa Rica 38
ES - Italia 38
JP - Giappone 38
PK - Pakistan 37
AT - Austria 36
ID - Indonesia 36
CO - Colombia 33
PL - Polonia 33
EC - Ecuador 29
MA - Marocco 28
SA - Arabia Saudita 26
BE - Belgio 25
IL - Israele 25
VE - Venezuela 24
CL - Cile 22
ZA - Sudafrica 22
CZ - Repubblica Ceca 20
UZ - Uzbekistan 20
HN - Honduras 19
PH - Filippine 19
PR - Porto Rico 18
GT - Guatemala 17
MY - Malesia 17
SC - Seychelles 17
CH - Svizzera 16
KE - Kenya 14
RO - Romania 14
SV - El Salvador 13
CW - ???statistics.table.value.countryCode.CW??? 12
TT - Trinidad e Tobago 12
NI - Nicaragua 11
PE - Perù 11
TN - Tunisia 11
AZ - Azerbaigian 10
EE - Estonia 10
JM - Giamaica 10
NP - Nepal 10
AE - Emirati Arabi Uniti 9
EG - Egitto 9
TG - Togo 9
ET - Etiopia 8
GP - Guadalupe 8
LT - Lituania 8
EU - Europa 7
KZ - Kazakistan 7
PY - Paraguay 7
UY - Uruguay 7
AU - Australia 6
DO - Repubblica Dominicana 6
JO - Giordania 6
PS - Palestinian Territory 6
RS - Serbia 6
BJ - Benin 5
HR - Croazia 5
HU - Ungheria 5
KG - Kirghizistan 5
LB - Libano 4
MD - Moldavia 4
NO - Norvegia 4
OM - Oman 4
PA - Panama 4
SY - Repubblica araba siriana 4
AL - Albania 3
AO - Angola 3
BH - Bahrain 3
BO - Bolivia 3
DZ - Algeria 3
GR - Grecia 3
LV - Lettonia 3
PT - Portogallo 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BB - Barbados 2
DK - Danimarca 2
Totale 22.815
Città #
Ashburn 1.314
Singapore 1.157
Southend 1.100
San Jose 1.050
Moscow 771
Chandler 704
Dallas 676
Hong Kong 452
Dublin 408
Jacksonville 405
Council Bluffs 381
The Dalles 335
Woodbridge 320
Beijing 313
Verona 305
Houston 172
Munich 161
Ann Arbor 160
Princeton 151
Lawrence 150
New York 148
Ho Chi Minh City 137
Wilmington 137
Los Angeles 129
Santa Clara 124
Helsinki 111
Hanoi 108
Nanjing 95
Jinan 91
Columbus 83
Buffalo 79
Shenyang 68
Milan 67
Redondo Beach 66
São Paulo 60
Tianjin 57
Abuja 55
Sindelfingen 46
Rome 45
Hebei 42
Frankfurt am Main 37
London 37
Seattle 37
Ningbo 36
Tokyo 36
Montreal 34
Nanchang 34
Changsha 33
Norwalk 33
Redwood City 31
Guangzhou 30
Las Vegas 30
Boardman 29
San José 29
Orem 28
Stockholm 28
Zhengzhou 28
Brooklyn 27
Turku 27
Falls Church 26
Taizhou 26
Atlanta 25
Toronto 25
Warsaw 25
Washington 25
Bologna 24
Chicago 24
San Francisco 24
Hangzhou 23
Nuremberg 23
Phoenix 23
Seoul 23
Chennai 21
Denver 21
Haikou 21
Brussels 20
Vienna 20
Brasília 18
Cambridge 18
Manchester 18
North Bergen 18
Tashkent 18
Poplar 17
Taiyuan 17
Da Nang 16
Jiaxing 16
Amsterdam 15
Brno 15
Des Moines 15
Mexico City 15
Campinas 14
Haiphong 14
Jakarta 14
Lahore 14
Madrid 14
Shanghai 14
Baghdad 13
Biên Hòa 13
Bogotá 13
Dong Ket 13
Totale 13.608
Nome #
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 558
'Recurrence of cholangiocarcinoma after surgical treatment: an analysis of modes of occurrence, risk factors, and results of treatment. 355
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 334
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 308
A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC) 285
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer 263
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 240
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 237
Impact of age on short-term outcomes of liver surgery: Lessons learned in 10-years' experience in a tertiary referral hepato-pancreato-biliary center 230
development of two nomograms for predicting major adverse cardiac events and death in patients admitted to the emergency department with chest pain 229
Prognostic value of portal hypertension after surgical resection of HCC in cirrhotic patients 224
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 224
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence 219
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. 218
Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. 218
Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery 210
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 208
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 207
Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System 206
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 205
Patterns and prognostic significance of lymph-node dissection for surgical treatment of peri-hilar and intrahepatic cholangiocarcinoma 203
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 200
Cholangiocarcinoma risk factors and the potential role of aspirin 200
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas 199
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma 198
Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection 198
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma 196
Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. 195
A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma 193
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 192
What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes 189
The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke 189
A machine learning analysis of difficulty scoring systems for laparoscopic liver surgery 185
Primary liver cancer: Prognostic factors and predictive response to therapy 185
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification 184
Liver Resection for Breast Cancer Liver Metastases A Cost-utility Analysis 175
Central Pancreatectomy: from Open to Minimally Invasive 175
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis 174
Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma 173
Complications after liver surgery: a benchmark analysis 172
Integrating Clinical Data and Molecular Profiling of Hepato-Pancreato-Biliary Cancers: a Surgical-pathological Approach 171
Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma 170
A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases 167
Defining Post Hepatectomy Liver Insufficiency: Where do We stand? 166
Tu1730 A Clinical Score Predicting the Occurence of Liver-Related Complications Following Hepatectomy 166
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme 166
Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery 165
Surgical Resection Versus Local Ablation for HCC on Cirrhosis: Results from a Propensity Case-Matched Study 163
Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis 162
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer 161
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 159
Pancreaticoduodenectomy with venous resection and reconstruction: current surgical techniques and associated postoperative imaging findings 155
Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes 153
Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection 151
Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma 151
Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery 151
Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy 150
Impact of Delta Hemoglobin on Provider Transfusion Practices and Post-operative Morbidity Among Patients Undergoing Liver and Pancreatic Surgery 149
A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population 147
ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma 147
Postoperative Omental Infarct After Distal Pancreatectomy: Appearance, Etiology Management, and Review of Literature 144
The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma 143
Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis 143
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation 142
Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma 142
Role of inflammatory and immune-nutritional prognostic markers in patients undergoing surgical resection for biliary tract cancers 142
Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study 139
Minimally Invasive vs. Open Hepatectomy: a Comparative Analysis of the National Surgical Quality Improvement Program Database 138
A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients 137
Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma 134
A Multi-Institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma 133
The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis 131
Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes 130
A novel online prognostic tool to predict long-term survival after liver resection for intrahepatic cholangiocarcinoma: The "metro-ticket" paradigm 129
Neuroendocrine liver metastasis: The chance to be cured after liver surgery 128
The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery 128
Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery 127
Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer 127
Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival 127
Quality of life after treatment of neuroendocrine liver metastasis 127
ASO Author Reflections: Minimally Invasive Surgery for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension 127
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma 126
Variation in Medicare Payments and Reimbursement Rates for Hepatopancreatic Surgery Based on Quality: Is There a Financial Incentive for High-Quality Hospitals? 126
Pancreatic Fistula and Delayed Gastric Emptying After Pancreatectomy: Where do We Stand? 125
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study 125
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy 124
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 124
Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment 123
Synergistic Effects of Perioperative Complications on 30-Day Mortality Following Hepatopancreatic Surgery 123
Infectious complications after surgery for perihilar cholangiocarcinoma: A single Western center experience 122
Nomogram to predict perioperative blood transfusion for hepatopancreaticobiliary and colorectal surgery 122
Liver transplantation in patients with liver metastases from neuroendocrine tumors 121
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent 120
Quality Versus Costs Related to Gastrointestinal Surgery: Disentangling the Value Proposition 119
Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma 117
Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis 116
The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample 116
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma 114
Surgical Procedures in Health Professional Shortage Areas: Impact of a Surgical Incentive Payment Plan 113
Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis 112
Totale 17.229
Categoria #
all - tutte 85.635
article - articoli 80.781
book - libri 0
conference - conferenze 3.151
curatela - curatele 0
other - altro 552
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.151
Totale 171.270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022558 0 0 0 0 28 32 24 75 40 31 43 285
2022/20232.317 181 231 241 359 171 609 26 124 261 20 66 28
2023/20241.129 54 93 105 103 159 195 43 112 6 51 140 68
2024/20253.337 185 217 112 560 213 177 166 201 447 224 277 558
2025/20269.447 691 377 673 1.291 2.089 658 977 544 982 682 183 300
2026/20272.010 112 297 399 1.053 149 0 0 0 0 0 0 0
Totale 23.067